Glaukos Corporation — Quarterly Financial Statistics (NYSE:GKOS) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities 507 K-18.52 M6.98 M-10.09 M6.84 M -14.79 M Cash from investing activities 11.79 M-36.95 M-20.78 M-3.99 M-15.89 M -77.61 M Cash from financing activities 60.11 M1.95 M2.25 M5.26 M2.43 M 11.89 M Free cash flow -1.23 M-20.46 M5.8 M-11.72 M3.93 M -22.45 M

News

Glaukos Wins Permanent J-Code for Epioxa Keratoconus Therapy

Glaukos Launches Epioxa, Boosts Growth in Corneal Treatments

Why Is Glaukos (GKOS) Down 14.7% Since Last Earnings Report?

Stifel reiterates Glaukos stock rating on product momentum

Glaukos Misses Q4 Earnings Estimates, Raises 2026 Revenue Outlook

Needham raises Glaukos stock price target on iDose, Epioxa growth

These Analysts Boost Their Forecasts On Glaukos Following Q4 Results - Glaukos (NYSE:GKOS)

Glaukos Corporation (GKOS) Q4 2025 Earnings Call Transcript

Glaukos (GKOS) Reports Q4 Earnings: What Key Metrics Have to Say

Glaukos (GKOS) Reports Q4 Loss, Beats Revenue Estimates

Glaukos earnings on deck as iDose, Epioxa launches converge

Globus Medical (GMED) to Report Q4 Results: Wall Street Expects Earnings Growth